Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast Cancer
Overview[ - collapse ][ - ]
| Purpose | Phase II study of neoadjuvant chemotherapy with Doxorubicin followed by Docetaxel-Cisplatin in locally advanced breast cancer |
|---|---|
| Condition | Breast Cancer |
| Intervention | Drug: Doxorubicin, Docetaxel, Cisplatin |
| Phase | N/A |
| Sponsor | King Faisal Specialist Hospital & Research Center |
| Responsible Party | King Faisal Specialist Hospital & Research Center |
| ClinicalTrials.gov Identifier | NCT00538525 |
| First Received | October 1, 2007 |
| Last Updated | May 26, 2012 |
| Last verified | May 2012 |
Tracking Information[ + expand ][ + ]
| First Received Date | October 1, 2007 |
|---|---|
| Last Updated Date | May 26, 2012 |
| Start Date | September 2007 |
| Estimated Primary Completion Date | April 2008 |
| Current Primary Outcome Measures | Effectiveness [Time Frame: overall] [Designated as safety issue: No] |
| Current Secondary Outcome Measures | Not Provided |
Descriptive Information[ + expand ][ + ]
| Brief Title | Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast Cancer |
|---|---|
| Official Title | Not Provided |
| Brief Summary | Phase II study of neoadjuvant chemotherapy with Doxorubicin followed by Docetaxel-Cisplatin in locally advanced breast cancer |
| Detailed Description | Not Provided |
| Study Type | Interventional |
| Study Phase | N/A |
| Study Design | Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment |
| Condition | Breast Cancer |
| Intervention | Drug: Doxorubicin, Docetaxel, Cisplatin Doxorubicin, Docetaxel, Cisplatin Other Names: Doxorubicin, Docetaxel, Cisplatin |
| Study Arm (s) | Active Comparator: Arm 1 Doxorubicin, Docetaxel, Cisplatin |
Recruitment Information[ + expand ][ + ]
| Recruitment Status | Completed |
|---|---|
| Estimated Enrollment | 10 |
| Estimated Completion Date | April 2008 |
| Estimated Primary Completion Date | April 2008 |
| Eligibility Criteria | Inclusion Criteria: - Patients with locally advanced breast cancer Exclusion Criteria: - Patients with metastatic breast cancer |
| Gender | Both |
| Ages | N/A |
| Accepts Healthy Volunteers | No |
| Contacts | Not Provided |
| Location Countries | Not Provided |
Administrative Information[ + expand ][ + ]
| NCT Number | NCT00538525 |
|---|---|
| Other Study ID Numbers | RAC#2011-022 |
| Has Data Monitoring Committee | Not Provided |
| Information Provided By | King Faisal Specialist Hospital & Research Center |
| Study Sponsor | King Faisal Specialist Hospital & Research Center |
| Collaborators | Not Provided |
| Investigators | Principal Investigator: Adnan Ezzat, MD KFSH&RC, Riyadh, Saudi Arabia |
| Verification Date | May 2012 |